NDC 55289-481-60
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55289-481
- Requested NDC
- 55289-481-60
- Package NDCs from labels
- 55289-481-60
- Manufacturer
- National Council for Prescription Drug Programs
- Effective date
- 2012-07-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 55289-481-30 | EA - Each | 55289-481 | 07a64ede-48e8-4037-90d9-a2e69c8fba30 | 1 | 2012-07-24 |
| 55289-481-60 | EA - Each | 55289-481 | 2663740b-cd0e-41c2-a485-f06ffb45344f | 1 | 2012-07-24 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levofloxacin | LEVOFLOXACIN | PD-Rx Pharmaceuticals, Inc. | 814450ae-439e-4a5d-8c60-9b21b6f14be5 | 2026-11-05 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Levocetirizine Dihydrochloride | LEVOCETIRIZINE DIHYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 344ba2d6-4e17-4cef-bd7b-248fbb1af3b6 | 2026-11-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Levetiracetam | LEVETIRACETAM | PD-Rx Pharmaceuticals, Inc. | c2177034-e164-453c-be02-1cf91ce27a07 | 2026-11-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| ZALEPLON | ZALEPLON | PD-Rx Pharmaceuticals, Inc. | 9c83b71e-8344-4c77-b7f6-a9c862f9e7dd | 2026-11-05 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Phendimetrazine Tartrate | PHENDIMETRAZINE TARTRATE | PD-Rx Pharmaceuticals, Inc. | 467ae7d7-e342-423b-be89-5d38c1abf3c9 | 2026-11-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ciprofloxacin | CIPROFLOXACIN | PD-Rx Pharmaceuticals, Inc. | 74e2dd24-5c6e-4dde-a2ab-f2d2e61734d8 | 2026-11-05 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Lovastatin | LOVASTATIN | PD-Rx Pharmaceuticals, Inc. | eea93a4b-f804-4b9c-aabf-e906f03c1e80 | 2026-11-05 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3a319017-4e25-402e-8ba0-63b9f1eb707e | 2026-11-04 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Nifedipine | NIFEDIPINE | PD-Rx Pharmaceuticals, Inc. | 75003769-7800-4bc7-b709-35b4caec2c2f | 2026-11-04 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Propranolol Hydrochloride | PROPRANOLOL HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 85973689-bb21-483f-becb-c5c8bfb05658 | 2026-11-04 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Metoprolol Succinate | METOPROLOL SUCCINATE | PD-Rx Pharmaceuticals, Inc. | 4d8cdd8b-3896-4cd0-9570-a6f4e1d340d7 | 2026-11-04 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6500c6eb-fa1e-46a5-839f-13047e107e97 | 2026-11-04 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Dexamethasone | DEXAMETHASONE | PD-Rx Pharmaceuticals, Inc. | a5609df4-4933-4f85-a7b8-bc54a70a2bac | 2026-11-04 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | PD-Rx Pharmaceuticals, Inc. | c182b6a9-1a31-45ee-9cea-a557c99f5db7 | 2026-11-04 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| PROCHLORPERAZINE MALEATE | PROCHLORPERAZINE MALEATE | PD-Rx Pharmaceuticals, Inc. | 3b022837-0fcc-d38a-e063-6394a90a0f7f | 2026-11-04 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ciprofloxacin | CIPROFOLXACIN | PD-Rx Pharmaceuticals, Inc. | 3b3c0874-90b7-deda-e063-6394a90a7802 | 2026-11-04 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Ciprofloxacin | CIPROFLOXACIN HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 3c611c8c-deed-4904-93f7-f75a2147fbf7 | 2026-11-04 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | PD-Rx Pharmaceuticals, Inc. | c1873a4c-661f-4896-bcc0-f6d3a655de94 | 2026-11-04 | Warnings | PD-Rx Pharmaceuticals, Inc. |
| DEXAMETHASONE | DEXAMETHASONE | PD-Rx Pharmaceuticals, Inc. | a8d6792e-757e-4dc6-adf5-0d9211075428 | 2026-11-04 | Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
| Etodolac | ETODOLAC | PD-Rx Pharmaceuticals, Inc. | 80e9d756-9278-48bb-bfdd-7d070ae0f341 | 2026-11-04 | Boxed warning, Warnings, Adverse reactions | PD-Rx Pharmaceuticals, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.